John Gill insider trades

Open-market stock purchases and sales by John Gill, Unknown at Altimmune, Inc, from SEC Form 4 filings since Jun 23, 2010.

Track record: 0% of 3 scored buys are up 5% or more since purchase, averaging -44%.

Recent trades

DateStockTradeValue
May 1, 2026ALT Altimmune, IncBought (not open market)—
Apr 6, 2026ALT Altimmune, IncBought$31.3K
Dec 23, 2025ALT Altimmune, IncBought$51.3K

Companies traded

  • ALT Altimmune, Inc: 3 buys, 2 sales, last May 1, 2026
  • PIP Pharmathene, Inc: other filings, last Nov 22, 2016

Get free alerts when John Gill files a new trade →